Dimebon®: A Clinically Promising Drug for Alzheimer's Disease, Regulates Amyloid-Beta Metabolism in Cultured Cells, In Isolated Nerve Terminals, and In the Interstitial Fluid of the Living Rodent Brain
Sam Gandy, John Cirrito, John Steele, Soong Ho Kim, Gopal Thinakaran, David Westaway, Paul Fraser, Peter St George Hyslop, Mary Sano, Ilya Bezprozvanny, Michelle E. Ehrlich, David M. HoltzmanТом:
5
Рік:
2009
Мова:
english
DOI:
10.1016/j.jalz.2009.07.133
Файл:
PDF, 55 KB
english, 2009
File converter
Більше результатів пошуку
More benefits 
